学校疫苗接种规划:2015/16年度英格兰学校免疫接种实施模式评估
该研究利用英格兰常规收集的国家数据,评估2015/16年度三种学校疫苗接种规划(HPV、MenACWY、Td/IPV)的实施模式对疫苗覆盖率的影响,以及一种规划的实施模式是否影响另一种规划。结果显示MenACWY和Td/IPV在较低年级覆盖率最高;HPV疫苗两种两剂次模式总体覆盖率相似(一年内两剂86.7% vs 两年内两剂85.8%,p=0.20);2013/14年度高覆盖率地区采用一年内两剂方案覆盖率更高(92.0% vs 85.2%,p<0.001)。
要点
- MenACWY和Td/IPV覆盖率在较低年级最高。
- HPV疫苗一年内两剂与两年内两剂总体覆盖率相似(86.7% vs 85.8%,p=0.20)。
- 2013/14高覆盖率地区采用一年内两剂方案覆盖率更高(92.0% vs 85.2%,p<0.001)。
核心结论
- 学校疫苗接种规划应尽早提供,且应在可接受的前提下尽早实施,以优化覆盖率。
- HPV疫苗实施模式的选择应考虑当地表现和提供者经验。
- 单一提供者可提供多种疫苗,一种规划的实施可能影响其他规划的表现。
- 提供者在决定采用何种实施模式时,应考虑当地情况,包括过去和当前的疫苗覆盖率以及影响覆盖率的因素。
研究设计与样本
- 分析英格兰常规收集的国家数据,评估2015/16年度三种学校疫苗接种规划(HPV、MenACWY、Td/IPV)的实施模式对疫苗覆盖率的影响。
- 确定每种单剂次规划中覆盖率最高的学校年级,并比较HPV疫苗两种两剂次实施模式(一年内完成 vs 跨两年完成)。
- 评估HPV实施模式是否与其他规划的覆盖率相关。
主要发现
- MenACWY和Td/IPV覆盖率在较低学校年级最高。
- HPV疫苗两种模式总体覆盖率相似:一年内两剂86.7% vs 跨两年两剂85.8%,p=0.20。
- 2013/14年度需三剂次时HPV高覆盖率地区,2015/16年度两剂次HPV覆盖率也高。
- 2013/14年度高覆盖率地区采用一年内两剂方案覆盖率更高:92.0% vs 85.2%,p<0.001。
- 2013/14年度低覆盖率地区在2015/16年度两种模式覆盖率均较低且相似:79.2% vs 80.9%,p=0.29。
关键数值与推荐
- HPV疫苗一年内两剂覆盖率86.7%,跨两年两剂覆盖率85.8%,p=0.20。
- 2013/14高覆盖率地区一年内两剂覆盖率92.0% vs 跨两年85.2%,p<0.001。
- 2013/14低覆盖率地区一年内两剂覆盖率79.2% vs 跨两年80.9%,p=0.29。
临床怎么用
- 学校疫苗接种规划应尽早提供,且应在可接受的前提下尽早实施,以优化覆盖率。
- HPV疫苗实施模式的选择应考虑当地表现和提供者经验。
- 提供者在决定采用何种实施模式时,应考虑当地情况,包括过去和当前的疫苗覆盖率以及影响覆盖率的因素。
- 单一提供者可提供多种疫苗,一种规划的实施可能影响其他规划的表现。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Schools are increasingly being used to deliver vaccines. In 2015/16 three school-based vaccination programmes were delivered to adolescents in England: human papillomavirus (HPV), meningococcal groups A, C, W and Y disease (MenACWY) and tetanus, diphtheria and polio (Td/IPV). We assessed how school delivery models impact vaccine coverage and how a delivery model for one programme may impact another. Routinely collected national data were analysed to ascertain the school grade achieving highest coverage within each one-dose programme and to compare two-dose delivery models (within year vs across years) for the HPV vaccine. We also assessed whether the HPV delivery model was associated with coverage in other programmes. MenACWY and Td/IPV coverage was highest in younger school grades. Overall similar HPV coverage was achieved with both models (86.7% two doses within one year, 85.8% two doses across two years, p = 0.20). High two-dose HPV coverage in 2015/16 was reported in areas that achieved high HPV coverage in 2013/14 when three doses were required. Areas with high three-dose coverage in 2013/14 achieved higher coverage with a within-one-year approach (92.0% vs 85.2%, p < 0.001), whilst areas reporting low coverage in 2013/14 achieved lower but similar coverage in 2015/16 with both models (79.2% vs 80.9% p = 0.29). MenACWY and Td/IPV coverage were higher in areas with high HPV coverage in 2013/14. Among high HPV coverage areas, MenACWY coverage was higher when HPV doses were delivered within year. School-based programmes should be offered as early as feasible and acceptable to optimise coverage. The choice of delivery model for HPV should take into account local performance and provider experience. Single providers may delivery multiple vaccines and the delivery for one programme may affect the performance of other programmes. Providers should consider local circumstances including past and current vaccine coverage and factors influencing coverage when deciding what delivery model to adopt.
引用
- Tiley K, Tessier E, White JM, et al. School-based vaccination programmes: An evaluation of school immunisation delivery models in England in 2015/16. Vaccine. 2020. PMID: 31980192. doi:10.1016/j.vaccine.2020.01.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。